April 2024

A listing of the individual articles included in the Jurisdiction F Medicare A News bulletin dated April 2024 is provided. Each article title functions as a hyperlink to a specific article.

paginationType regular
Articles Source
Billing and Coding: MolDX: MCOLN1 Genetic Testing (A55284) Retirement - Effective May 23, 2024
Billing and Coding: MolDX: MECP2 Genetic Testing (A55286) Retirement - Effective April 26, 2024
Billing and Coding: MolDX: Microsatellite Instability-High (MSI-H) and Mismatch Repair Deficient (dMMR) Biomarker for Patients with Unresectable or Metastatic Solid Tumors (A56104) - R5 - Effective January 1, 2024
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58456) - R6- January 1, 2024
Billing and Coding: MolDX: Mitochondrial Nuclear Gene Tests (A55291) Retirement - Effective May 29, 2024
Billing and Coding: MolDX: MMACHC Test (A55289) Retirement - Effective May 30, 2024
Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (A58724 ) - R3 - Effective March 12, 2024
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57527) - R16- January 1, 2024
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57527) - R17 - Effective January 1, 2024
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57527) - R18 - Effective April 01, 2024
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58726) - R15 - January 1, 2024
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58726) - R16 - Effective April 17, 2022
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58726) - R17 - Effective February 29, 2024
Billing and Coding: MolDX: Molecular Testing for Solid Organ Allograft Rejection (A58170) - R6 - Effective February 29, 2024
Billing and Coding: MolDX: myPap™ (A55293) Retirement - Effective April 19, 2024
Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors (A57905) - R6 - Effective January 1, 2024
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (A57892) - R7 - Effective January 1, 2024
Billing and Coding: MolDX: NSD1 Gene Tests (A55615) Retirement - Effective April 30, 2024
Billing and Coding: MolDX: PAX6 Gene Sequencing (A55632) Retirement - Effective May 29, 2024
Billing and Coding: MolDX: Pharmacogenomics Testing (A57385) - R13 - Effective January 25, 2024
Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors (A58975) - R4 - Effective January 1, 2024
Billing and Coding: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer (A58187) - R7 - Effective January 1, 2024
Billing and Coding: MolDX: Prometheus® IBD sgi Diagnostic® Policy (A57517) - R3 - Effective October 20, 2022
Billing and Coding: MolDX: Proteomics Testing (A59642) - Effective January 31, 2024
Billing and Coding: MolDX: Proteomics Testing (A59642) - R1 - Effective January 31, 2024
Billing and Coding: MolDX: Proteomics Testing (A59642) - R2 - Effective January 31, 2024
Billing and Coding: MolDX: Proteomics Testing (A59642) - R3 - Effective April 1, 2024
Billing and Coding: MolDX: Proteomics Testing (A59642) - R4 - Effective May 30, 2024
Billing and Coding: MolDX: PTCH1 Gene Testing (A55618) Retirement - Effective April 25, 2024
Billing and Coding: MolDX: Repeat Germline Testing (A57332) - R10 - January 1, 2024
Billing and Coding: MolDX: Repeat Germline Testing (A57332) - R11 - Effective April 1, 2024
Billing and Coding: MolDX: RPS19 Gene Tests (A55614) Retirement - Effective April 30, 2024
Billing and Coding: MolDX: Short Tandem Repeat (STR) Markers and Chimerism (CPT® codes 81265-81268) (A57843) - R3 - Effective April 4, 2024
Billing and Coding: MolDX: SMPD1 Genetic Testing (A55631) Retirement - Effective May 21, 2024
Billing and Coding: MolDX: STAT3 Gene Testing (A55481) Retirement - Effective April 24, 2024
Billing and Coding: MolDX: Targeted and Comprehensive Genomic Profile Next-Generation Sequencing Testing in Cancer (A56518) - R8 - Effective March 21, 2024
Billing and Coding: MolDX: TERC Gene Tests (A55616) Retirement - Effective May 1, 2024
Billing and Coding: MolDX: TP53 Gene Tests (A55487) Retirement - Effective May 1, 2024
Billing and Coding: MolDX: VEGFR2 Tests (A55469) Retirement - Effective April 23, 2024
Billing and Coding: Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF) (A56573) - R5 - Effective January 10, 2021
Billing and Coding: Peripheral Nerve Stimulation (A55531) - R7 - Effective March 1, 2024
Billing and Coding: Sacroiliac Joint Injections and Procedures (A59244) - R5 - Effective June 1, 2024
Billing and Coding: Serum Magnesium (A57198) - R8 - Effective October 1, 2023
Billing and Coding: Trigger Point Injections (A57702) - R5 - Effective April 1, 2024
Billing and Coding: Wound and Ulcer Care (A58567) - R6 - Effective April 1, 2024
Billing Requirements for IOP Services for Federally Qualified Health Centers & Rural Health Clinics CR13264
Billing the Subsequent Inpatient Care 99232 Correctly - Appeals Newsletter Part 9
Change Healthcare Security Incident - Resolved 04/24/24 Alert
Changes to the Laboratory NCD Edit Software: July 2024 Update CR13554
Clinical Laboratory Fee Schedule & Laboratory Services Reasonable Charge Payment: Quarterly Update CR13613
— 50 Items per Page
Showing 51 - 100 of 208 results.